Lexicon PharmaceuticalsLXRX
那斯達克 · USD
1.55
+0.03
(+1.97%)
收盤 10/20 03:59 (UTC+8)
10/20 03:59 (UTC+8)
Lexicon PharmaceuticalsLXRX
1.55
+0.03
(+1.97%)
財務數據
損益表
- 0.01
- 0.02
- 0.02
- 0.27
- 0.01
- 0.29
- 0.14
- 0.05
- 0.21
- 0.01
- 60.97
- 45.75
- 6.25
- 1417.37
- -95.25
- 2187.32
- -50.87
- -61.27
- 284.16
- -96.72
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 692 | 21,102 | 5,493 | 14,182 | 28,866 | 1,262 | 26,554 | 1,750 | 1,647 | 1,130 |
營業成本 | 39 | 108 | 201 | 10 | 33 | 30 | 348 | 71 | 166 | 31 |
營業毛利 | 653 | 20,994 | 5,292 | 14,172 | 28,833 | 1,232 | 26,206 | 1,679 | 1,481 | 1,099 |
營業費用 | 27,193 | 21,990 | 20,072 | 26,360 | 25,097 | 26,911 | 58,943 | - | - | 46,432 |
研發費用 | 17,443 | 12,756 | 11,315 | 18,756 | 15,747 | 15,303 | 26,685 | 25,780 | 17,643 | 14,372 |
推銷及管理費用 | 9,750 | 9,234 | 8,757 | 7,604 | 9,350 | 11,608 | 32,258 | 39,592 | 39,192 | 32,060 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -26,540 | -996 | -14,780 | -12,188 | 3,736 | -25,679 | -32,737 | -63,693 | -55,354 | -45,333 |
其他收入及費用 | -2,626 | 1,543 | 1,281 | 1,575 | 1,834 | 2,219 | 2,829 | 3,444 | 4,136 | 1,884 |
利息費用 | 2,609 | 1,590 | 2,031 | 2,155 | 2,318 | 1,835 | 3,858 | 4,562 | 2,211 | 4,948 |
稅前純益 | -31,775 | -1,043 | -15,530 | -12,768 | 3,252 | -25,295 | -33,766 | -64,811 | -53,429 | -48,397 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -31,775 | -1,043 | -15,530 | -12,768 | 3,252 | -25,295 | -33,766 | -64,811 | -53,429 | -48,397 |
基本每股稅後盈餘(元) | -0.07 | - | -0.04 | -0.04 | 0.01 | -0.07 | -0.09 | -0.18 | -0.17 | -0.20 |
稀釋每股稅後盈餘(元) | -0.08 | - | -0.04 | -0.04 | 0.01 | -0.07 | -0.09 | -0.17 | -0.17 | -0.20 |
基本平均股數(千股) | 437653.00 | 400240.00 | 363428.00 | 363399.00 | 363294.00 | 362073.00 | 361492.00 | 361492.00 | 310836.00 | 245390.00 |
稀釋平均股數(千股) | 437653.00 | 400240.00 | 363428.00 | 363399.00 | 363570.00 | 362073.00 | 361492.00 | 361492.00 | 310836.00 | 245390.00 |
還原基本每股稅後盈餘(元) | -0.07 | - | -0.04 | -0.04 | 0.01 | -0.07 | -0.09 | -0.18 | -0.17 | -0.20 |
還原稀釋每股稅後盈餘(元) | -0.08 | - | -0.04 | -0.04 | 0.01 | -0.07 | -0.09 | -0.17 | -0.17 | -0.20 |
還原基本平均股數(千股) | 437,653 | 400,240 | 363,428 | 363,399 | 363,294 | 362,073 | 361,492 | 361,492 | 310,836 | 245,390 |
還原稀釋平均股數(千股) | 437,653 | 400,240 | 363,428 | 363,399 | 363,570 | 362,073 | 361,492 | 361,492 | 310,836 | 245,390 |
EBITDA(千元) | -29,262 | 776 | -13,326 | -10,792 | 4,934 | -24,209 | -31,269 | -67,139 | -49,155 | -42,788 |